These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 37409358)

  • 1. Prolonged mucosal topical application of cyclosporin A for severe stomatitis of paraneoplastic pemphigus.
    Hashimoto K; Kobayashi K; Nakamura Y; Yukino Y; Tsuji G; Kim H; Kataoka K; Amagai M
    Australas J Dermatol; 2023 Aug; 64(3):439-441. PubMed ID: 37409358
    [No Abstract]   [Full Text] [Related]  

  • 2. Paraneoplastic pemphigus associated with fatal bronchiolitis obliterans and intractable mucosal erosions: Treatment with cyclosporin in addition to steroid, rituximab and intravenous immunoglobulin.
    Namba C; Tohyama M; Hanakawa Y; Murakami M; Shirakata Y; Matsumoto T; Suemori K; Ishii N; Hashimoto T; Sayama K
    J Dermatol; 2016 Apr; 43(4):419-22. PubMed ID: 26506947
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Topical tacrolimus (FK506) for relapsing erosive stomatitis in paraneoplastic pemphigus.
    Vecchietti G; Kerl K; Hügli A; Samson J; Borradori L
    Br J Dermatol; 2003 Apr; 148(4):833-4. PubMed ID: 12752158
    [No Abstract]   [Full Text] [Related]  

  • 4. Successful treatment of B cell chronic lymphocytic leukemia-associated severe paraneoplastic pemphigus with cyclosporin A.
    Gergely L; Váróczy L; Vadász G; Remenyik E; Illés A
    Acta Haematol; 2003; 109(4):202-5. PubMed ID: 12853695
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Novel Use of Topical Ketamine for the Treatment of Oral Pemphigus: A Case Report.
    Higgins EA; West JA
    J Palliat Care; 2021 Jul; 36(3):146-147. PubMed ID: 32713289
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Paraneoplastic Pemphigus. A Life-Threatening Autoimmune Blistering Disease.
    Tirado-Sánchez A; Bonifaz A
    Actas Dermosifiliogr; 2017 Dec; 108(10):902-910. PubMed ID: 28801011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Successful immunomodulatory therapy in castleman disease with paraneoplastic pemphigus vulgaris.
    Miltenyi Z; Toth J; Gonda A; Tar I; Remenyik E; Illes A
    Pathol Oncol Res; 2009 Sep; 15(3):375-81. PubMed ID: 19067241
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Paraneoplastic pemphigus: a refractory autoimmune mucocutaneous disease.
    Ng PP; Rencic A; Nousari HC
    J Cutan Med Surg; 2002; 6(5):434-7. PubMed ID: 12196890
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Paraneoplastic pemphigus secondary to fludarabine evolving into unusual oral pemphigus vegetans.
    Powell AM; Albert S; Oyama N; Sakuma-Oyama Y; Bhogal B; Black MM
    J Eur Acad Dermatol Venereol; 2004 May; 18(3):360-4. PubMed ID: 15096157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recalcitrant paraneoplastic pemphigus associated with follicular dendritic cell sarcoma: response to prolonged rituximab and ciclosporin therapy.
    Hwang YY; Chan JC; Trendell-Smith NJ; Kwong YL
    Intern Med J; 2014 Nov; 44(11):1145-6. PubMed ID: 25367731
    [No Abstract]   [Full Text] [Related]  

  • 11. Paraneoplastic pemphigus associated with uterine carcinoma.
    Niimi Y; Kawana S; Hashimoto T; Kusunoki T
    J Am Acad Dermatol; 2003 May; 48(5 Suppl):S69-72. PubMed ID: 12734481
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Paraneoplastic pemphigus treated with dexamethasone/ cyclophosphamide pulse therapy.
    Becker LR; Bastian BC; Wesselmann U; Karl S; Hamm H; Bröcker EB
    Eur J Dermatol; 1998 Dec; 8(8):551-3. PubMed ID: 9889426
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Paraneoplastic pemphigus as the first manifestation of follicular dendritic cell sarcoma.
    Liu KL; Shen JL; Yang CS; Chen YJ
    J Dtsch Dermatol Ges; 2014 Jan; 12(1):68-71. PubMed ID: 24119156
    [No Abstract]   [Full Text] [Related]  

  • 14. Current management strategies in paraneoplastic pemphigus (paraneoplastic autoimmune multiorgan syndrome).
    Frew JW; Murrell DF
    Dermatol Clin; 2011 Oct; 29(4):607-12. PubMed ID: 21925005
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Paraneoplastic Pemphigus: Autoimmune-Cancer Nexus in the Skin.
    Sinha AA
    Anticancer Agents Med Chem; 2015; 15(10):1215-23. PubMed ID: 26179266
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A case of follicular lymphoma complicated with lethal pemphigus].
    Imataki O; Tamai Y; Abe Y; Ito I; Yoshikawa S; Kawakami K
    Gan To Kagaku Ryoho; 2006 Nov; 33(11):1677-80. PubMed ID: 17108741
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systemic retinoid treatment in a case of hyperkeratotic lichenoid paraneoplastic pemphigus.
    Yendo TM; Miyamoto D; Santi CG
    Int J Dermatol; 2022 Feb; 61(2):231-233. PubMed ID: 34351632
    [No Abstract]   [Full Text] [Related]  

  • 18. Therapy of paraneoplastic pemphigus with Rituximab: A case report.
    Zhang H; Hu B; Chen H; Wan L; Chen J; Zhou X; Chen L
    Dermatol Ther; 2021 Nov; 34(6):e15144. PubMed ID: 34582076
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Successful use of intravenous and intralesional rituximab in paraneoplastic pemphigus with Castleman's disease.
    Viswanath V; Tare D; Patil PC
    Int J Dermatol; 2021 Sep; 60(9):e352-e354. PubMed ID: 33720390
    [No Abstract]   [Full Text] [Related]  

  • 20. Budesonide for local therapy of complex oral mucosal immune-mediated inflammatory diseases: case reports.
    Utsman RA; Epstein JB; Elad S
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2008 Jul; 106(1):e11-7. PubMed ID: 18585605
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.